×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1 - Non-clinical Safety Assessment of Cell Therapy Products
Session Chair(s)
Sumimasa Nagai, MD, PhD
Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan
Yoji Sato, PhD
Head, Division of Drugs
National Institute of Health Sciences, Japan
Speaker(s)
Positioning of General Toxicology Studies in Cell Therapy Products
Satoshi Yasuda, PhD
National Institute of Health Sciences, Japan
Chief, Division of Cell-Based Therapeutic Products
Points to Consider for the Standardization of Tumorigenicity Testing
Hiroto Bando, PhD, MBA
FUJIFILM Corporation, Japan
Senior Manager, Pharmaceutical Products Division
Viral Safety for Porcine Islet Xenotransplantation
Masayuki Shimoda, MD, PhD
National Center for Global Health and Medicine, Japan
Project Leader, Research Institute
Have an account?